| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥338.6B | ¥324.1B | +4.5% |
| Operating Income | ¥33.3B | ¥65.7B | -49.2% |
| Ordinary Income | ¥32.0B | ¥81.9B | -60.9% |
| Net Income | ¥14.5B | ¥5.9B | +146.2% |
| ROE | 2.5% | 1.0% | - |
Fiscal 2025 full-year results show revenue of 338.6B yen (up 4.5% YoY from 324.1B yen) but operating income declined sharply to 33.3B yen (down 49.2% from 65.7B yen), reflecting significant profitability deterioration. Operating margin compressed to 9.8% from approximately 20.3% in the prior year. Ordinary income fell 60.9% to 32.0B yen, while net income increased 146.2% to 14.5B yen, primarily due to extraordinary gains of 10.3B yen. The gap between operating performance and net income reflects non-recurring factors requiring careful interpretation. Basic EPS declined to 73.30 yen from 145.31 yen. Despite profit challenges, cash generation remained robust with operating CF of 85.3B yen (up 68.9%) and free cash flow of 87.8B yen, demonstrating strong cash-backed earnings quality. The company executed aggressive shareholder returns including 41.9B yen in share buybacks alongside dividends. Balance sheet health remains solid with equity ratio of 66.9% and current ratio of 285.6%, though working capital efficiency deteriorated with inventory days reaching 280 days and work-in-process inventory comprising 72.9% of total inventory.
Revenue increased 4.5% to 338.6B yen, driven by deposition equipment deliveries in the single business segment. The company operates exclusively in deposition equipment manufacturing, and revenue growth reflects order fulfillment timing and customer demand cycles. However, profitability deteriorated significantly as gross margin compressed to 33.8% from an implied 37.8% in the prior year, with cost of sales rising to 224.2B yen (66.2% of revenue versus approximately 62% previously). SG&A expenses increased to 81.1B yen (23.9% of revenue), contributing to operating margin compression from approximately 20% to 9.8%. Operating income fell 49.2% to 33.3B yen, representing the primary driver of overall profit decline. Non-operating items showed net expense of 1.3B yen (non-operating income of 5.8B yen offset by expenses of 7.2B yen), including FX gains of 4.4B yen and FX losses of 3.2B yen reflecting currency volatility, plus interest expense of 2.0B yen. The gap between operating income of 33.3B yen and ordinary income of 32.0B yen of 1.3B yen is modest and explained by the net non-operating balance. Extraordinarily, the company recorded gains of 10.3B yen versus losses of only 0.1B yen, providing significant one-time support to net income. This non-recurring factor explains why net income of 14.5B yen increased 146.2% despite operating income declining 49.2%. Tax expense of 13.8B yen on profit before tax of 42.2B yen represents an effective tax rate of 32.7%. The comprehensive income statement shows other comprehensive income items totaling 38.2B yen, primarily valuation gains on securities of 23.9B yen and FX translation adjustments of 3.8B yen. This represents a "revenue up, profit down" pattern with revenue growth failing to translate into operating profit due to cost pressures and margin compression, though extraordinary gains temporarily supported net income.
The company operates a single business segment in deposition equipment manufacturing, hence segment-level breakdown is not applicable per disclosure notes. The entire business focuses on development, manufacturing and sales of deposition equipment systems.
[Profitability] ROE of 2.5% declined substantially from prior year levels, driven primarily by net profit margin compression to 8.7% (calculated as net income 29.6B yen divided by revenue 338.6B yen based on comprehensive income attribution). Operating margin of 9.8% represents a significant deterioration from approximately 20.3% in the prior year, declining 10.5 percentage points. The DuPont decomposition shows ROE of 2.5% (using reported consolidated equity and comprehensive income to parent) results from net profit margin of 8.7%, asset turnover of 0.393, and financial leverage of 1.50x, with margin compression being the dominant factor. Gross profit margin of 33.8% also declined from an implied 37.8% previously. [Cash Quality] Cash and deposits stood at 314.4B yen, providing coverage of 78.6x against short-term debt of 4.0B yen and 1.58x against total current liabilities of 198.8B yen. Operating CF to net income ratio of 5.88x (using reported net income of 14.5B yen) demonstrates strong cash-backed earnings, though this ratio is inflated by the depressed net income base. OCF to EBITDA ratio of 1.95x and negative accrual ratio of -6.5% confirm high earnings quality from a cash perspective. [Investment Efficiency] Total asset turnover of 0.393 reflects capital intensity, while inventory days of 280 days and cash conversion cycle of 270 days indicate significant working capital inefficiency requiring management attention. Work-in-process inventory represents 72.9% of total inventory of 172.0B yen, suggesting production bottlenecks. [Financial Health] Equity ratio of 66.9% (576.1B yen equity against 861.5B yen total assets) reflects conservative capitalization. Current ratio of 285.6% (567.8B yen current assets against 198.8B yen current liabilities) demonstrates strong liquidity. Interest-bearing debt totals only 4.0B yen (short-term borrowings), resulting in debt-to-equity ratio of 0.01x and net cash position of 310.4B yen. The balance sheet shows minimal financial leverage with debt-to-capital ratio of 0.7%.
Operating CF of 85.3B yen increased 68.9% YoY, driven by operating CF subtotal before working capital of 96.0B yen and favorable working capital movements including a 29.0B yen increase in payables partially offset by 6.7B yen inventory increase and 5.5B yen receivables increase. Contract liabilities increased 20.6B yen, contributing positively to operating cash generation and reflecting advance payments from customers. Income taxes paid of 13.7B yen and interest and dividends received of 3.1B yen represent additional CF components. The operating CF to net income ratio of 5.88x (using reported net income of 14.5B yen) demonstrates strong cash conversion, though the ratio reflects suppressed net income from extraordinary items. Investing CF showed net inflow of 2.6B yen despite CapEx of 9.9B yen, suggesting asset disposals or investment recoveries exceeded capital expenditure. The CapEx to depreciation ratio of 0.95x indicates maintenance-level capital spending. Financing CF of negative 62.6B yen reflected aggressive capital allocation with share buybacks of 41.9B yen and dividend payments estimated at approximately 21.3B yen based on dividend per share and outstanding shares. FCF of 87.8B yen demonstrates robust cash generation capacity. Depreciation and amortization of 10.4B yen represents non-cash charges included in operating income. The substantial increase in payables by 29.0B yen (from 10.8B yen to 42.4B yen, up 291%) warrants monitoring as it may indicate extended payment terms utilized for working capital management.
Ordinary income of 32.0B yen versus operating income of 33.3B yen shows net non-operating expense of 1.3B yen, representing 0.4% of revenue and consisting primarily of interest expense of 2.0B yen net of interest income of 2.5B yen, plus net FX impact of 1.2B yen (gains of 4.4B yen offset by losses of 3.2B yen). Equity method loss of 1.3B yen also contributed to non-operating expenses. The relative stability between operating and ordinary income suggests limited reliance on non-operating items for core profitability. However, extraordinary gains of 10.3B yen versus extraordinary losses of only 0.1B yen represent 3.0% of revenue and constitute a significant non-recurring factor that boosted net income. Excluding these extraordinary items, normalized net income would have been substantially lower, highlighting that reported net income growth of 146.2% is not representative of underlying operating performance. Operating CF of 85.3B yen significantly exceeds net income of 14.5B yen, with OCF representing 5.88x net income, indicating healthy cash-backed earnings quality. The negative accrual ratio of -6.5% confirms that earnings are supported by strong cash generation rather than accounting accruals. Comprehensive income of 52.7B yen to parent (53.6B yen total) exceeds net income by 38.2B yen due to unrealized valuation gains on securities of 23.9B yen and FX translation adjustments of 3.8B yen, reflecting mark-to-market gains that do not impact current cash but affect total equity through other comprehensive income.
Full-year forecast projects revenue of 382.0B yen (up 12.8% YoY), operating income of 62.0B yen (up 85.9%), and ordinary income of 74.0B yen (up 131.1%). Current period achievement rates are 88.6% for revenue, 53.7% for operating income, and 43.3% for ordinary income. Operating income and ordinary income achievement rates are significantly below the standard 100% completion rate for full-year results, indicating the forecast represents forward guidance for the next fiscal period rather than achievement against current period targets. The substantial projected increases in operating income (up 85.9%) and ordinary income (up 131.1%) imply expected recovery in profitability margins from current depressed levels of 9.8% operating margin toward approximately 16.2% (62.0B yen divided by 382.0B yen). Forecast EPS of 140.48 yen represents near-doubling from current 73.30 yen, consistent with the projected profit recovery. Contract liabilities of 114.9B yen provide forward revenue visibility, representing 30.1% of forecasted revenue or approximately 3.6 months of sales, suggesting a reasonable backlog though not exceptionally high for the capital equipment industry. Management notes that forecasts are based on currently available information and actual results may differ materially due to various factors. An investor briefing is scheduled for February 13, 2026, with materials to be posted on the corporate website, which should provide detailed assumptions underlying the recovery forecast.
Annual dividend totaled 54.0 yen per share (interim 26.0 yen, year-end 28.0 yen per forecast), compared to prior year dividend levels. Payout ratio is reported at 35.8%, though calculation based on disclosed figures suggests potential definitional differences (54.0 yen times outstanding shares versus net income yields different ratios depending on share count and income attribution used). Share buybacks totaling 41.9B yen were executed during the period, representing significant capital allocation to shareholder returns alongside dividends. Total shareholder return combining dividends (estimated 21.3B yen based on shares outstanding) and buybacks (41.9B yen) totals approximately 63.2B yen. Free cash flow of 87.8B yen provides coverage of 1.39x for total shareholder returns, indicating sustainable capital allocation from operating cash generation. The aggressive buyback program reduced shares outstanding with treasury stock increasing from 43.4B yen to 75.7B yen (up 32.3B yen or 74.6%), reflecting management's commitment to shareholder value enhancement. However, the simultaneous execution of substantial buybacks alongside dividends while operating margins are under pressure warrants monitoring to ensure appropriate balance between shareholder returns and reinvestment in operational improvement initiatives.
Order and delivery timing volatility represents significant earnings risk, as the company operates in capital equipment manufacturing where large-scale deposition equipment orders create lumpy revenue patterns depending on customer investment cycles and project completion milestones. Current period revenue growth of 4.5% alongside 49.2% operating income decline demonstrates sensitivity to product mix and cost structure fluctuations. Working capital efficiency deterioration poses operational and financial risk, evidenced by inventory days of 280 days (versus industry benchmark below 60 days) and cash conversion cycle of 270 days (versus benchmark below 60 days). Work-in-process inventory comprising 72.9% of total inventory (125.4B yen of 172.0B yen) suggests production bottlenecks or project execution delays that tie up capital and create obsolescence risk if customer requirements change. The 6.7B yen inventory increase despite revenue growth indicates potential overproduction or slower-than-expected order conversion. Margin compression risk from cost structure and pricing pressure is evident in gross margin decline to 33.8% and operating margin compression to 9.8% from approximately 20% previously. Cost of sales increased to 66.2% of revenue from approximately 62%, while SG&A ratio of 23.9% remained elevated. Management's ability to restore margins toward the forecasted 16.2% operating margin depends on successful cost control initiatives, favorable product mix, and pricing discipline. Accounts payable increased 291% to 42.4B yen, which while improving cash conversion in the short term, may indicate extended payment terms that could pressure supplier relationships if not managed carefully, and creates refinancing risk if payment obligations accelerate.
[Industry Position] (Reference - Proprietary Analysis) The company operates in specialized capital equipment manufacturing for deposition systems. Within the semiconductor and electronics capital equipment sector, the company's profitability profile has weakened below typical industry standards. Operating margin of 9.8% in the current period represents significant underperformance relative to historical company levels and sector expectations for specialized equipment manufacturers, where margins typically range 15-25%. The company's ROE of 2.5% falls well short of industry median ranges of 8-12% for capital equipment suppliers, primarily driven by margin compression rather than capital efficiency or leverage issues. Financial health metrics remain superior to industry norms, with equity ratio of 66.9% exceeding typical ranges of 40-50% and minimal debt utilization providing substantially stronger balance sheet positioning than peers. Cash conversion cycle of 270 days significantly exceeds industry benchmarks of 60-90 days, indicating inferior working capital management particularly in inventory efficiency. The company's conservative financial structure (low debt, high cash) provides strategic flexibility but also suggests potential underutilization of capital for growth initiatives. Historical trend data shows the company achieved stronger profitability in prior periods, suggesting current weakness may be cyclical rather than structural, pending validation through forecast achievement. Industry comparison based on Proprietary Analysis of capital equipment manufacturers.
Operating margin recovery trajectory represents the critical variable for investment evaluation, as current period margin of 9.8% reflects substantial deterioration from historical 20% levels while management forecasts recovery to approximately 16.2% in the next period. Achievement of forecasted 85.9% operating income growth would validate management's ability to address cost structure issues and restore profitability closer to historical norms and industry standards, whereas continued margin pressure would signal more fundamental competitive or operational challenges. The divergence between strong cash generation (operating CF of 85.3B yen, OCF/net income of 5.88x) and weak operating profitability (operating income down 49.2%) highlights that current earnings quality from a cash perspective remains intact despite accounting profit deterioration, providing a foundation for recovery if operational improvements materialize. Working capital efficiency improvement serves as a tangible operational indicator to monitor, with inventory days of 280 days and work-in-process ratio of 72.9% indicating clear opportunities for cash release and operational optimization. Reduction in these metrics toward industry norms would unlock significant cash and validate improved execution capability. The company's substantial capital allocation to shareholder returns (41.9B yen buybacks plus dividends from FCF of 87.8B yen) demonstrates financial flexibility and shareholder orientation, though sustainability depends on achieving forecasted profit recovery to maintain earnings-based payout ratios while preserving balance sheet strength.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.